As Technologies for Nucleotide Therapeutics Mature, Products Emerge

• Asıl Yazarlar: Jennifer M. Beierlein (Yazar), Laura M. McNamee (Yazar), Fred D. Ledley (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2017-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

The long path from initial research on oligonucleotide therapies to approval of antisense products is not unfamiliar. This lag resembles those encountered with monoclonal antibodies, gene therapies, and many biological targets and is consistent with studies of innovation showing that technology matu...